RHUMBLINE ADVISERS - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 51 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2023$950
-22.3%
1,0920.0%0.00%
Q2 2023$1,223
-97.6%
1,092
-97.0%
0.00%
Q1 2019$50,000
+25.0%
36,309
-1.8%
0.00%
Q4 2018$40,000
-73.9%
36,979
+48.5%
0.00%
Q3 2018$153,000
-46.3%
24,903
-6.7%
0.00%
-100.0%
Q2 2018$285,000
+42.5%
26,703
+43.2%
0.00%
Q1 2018$200,000
+61.3%
18,646
+5.6%
0.00%
Q4 2017$124,000
-35.1%
17,656
-19.1%
0.00%
Q3 2017$191,000
-3.5%
21,821
+0.4%
0.00%
Q2 2017$198,00021,7260.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q2 2019
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders